Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Online First

December 05, 2018

Correspondence
Paradoxical pulmonary event under tocilizumab treatment for systemic sclerosis-associated usual interstitial pneumonia
Free

Ana Luisa Oliveira, Carina Ruano, Nuno Riso, José Cepeda Ribeiro, Maria Francisca Moraes-Fontes

doi: 10.1136/annrheumdis-2018-214747

December 04, 2018

Correspondence response
Harmonisation of laboratory tests for rheumatic diseases: still a long way to go
Free

Lieve Van Hoovels, Xavier Bossuyt

doi: 10.1136/annrheumdis-2018-214696

December 01, 2018

Correspondence response
Response to: “Antinuclear autoantibodies: discordance among four different assays” by Pacheco et al
Free

David S Pisetsky, Diane M Spencer, Peter E Lipsky, Brad Rovin

doi: 10.1136/annrheumdis-2018-214766
Correspondence
Effectiveness of low-dose radiation therapy on symptoms in patients with knee osteoarthritis
Free

Xiang-Dong Wu, Ke-Jia Hu, Bing-Yan Xiang, Wei Huang

doi: 10.1136/annrheumdis-2018-214743

November 28, 2018

Letter
3D culture of Erdheim-Chester disease tissues unveils histiocyte metabolism as a new therapeutic target

Antonello Villa, Daniela Belloni, Barbara Vergani, Simone Cenci, Giulio Cavalli, Riccardo Biavasco, Monica Rodolfo, Maria Giulia Cangi, Claudio Doglioni, Lorenzo Dagna, Elisabetta Ferrero, Marina Ferrarini

doi: 10.1136/annrheumdis-2018-214432
Correspondence
Predictive factors of pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids
Free

Julia Herrou, Victoire De Lastours

doi: 10.1136/annrheumdis-2018-214718
Correspondence
OCTA, a sensitive screening for asymptomatic retinopathy, raises alarm over systemic involvements in patients with SLE
Free

Yumiko Mizuno, Masayuki Nishide, Taku Wakabayashi, Kohji Nishida, Atsushi Kumanogoh

doi: 10.1136/annrheumdis-2018-214751
Correspondence
Mandatory, cost-driven switching from originator etanercept to its biosimilar SB₄: possible fallout on non-medical switching
Free

Fabrizio Cantini, Maurizio Benucci

doi: 10.1136/annrheumdis-2018-214757

November 24, 2018

Correspondence
Some concerns from Turkey
Free

Emre Bilgin, İrem Ozarli, Levent Kılıç, Ertuğrul Çağrı Bölek, Gözde Kübra Yardımcı, Ömer Karadağ

doi: 10.1136/annrheumdis-2018-214739
Correspondence
Prevention of infections in patients with antineutrophil cytoplasm antibody-associated vasculitis: potential role of hydroxychloroquine
Free

Pavel I Novikov, Nikolai M Bulanov, Anastasiia S Zykova, Sergey V Moiseev

doi: 10.1136/annrheumdis-2018-214508

November 20, 2018

Correspondence
Antinuclear autoantibodies: discordance among four different assays
Free

Yovana Pacheco, Diana M Monsalve, Yeny Acosta-Ampudia, Cilia Rojas, Juan-Manuel Anaya, Carolina Ramírez-Santana

doi: 10.1136/annrheumdis-2018-214693

November 17, 2018

Correspondence
ANA testing in ‘real life’
Free

Maria Infantino, Mariangela Manfredi, Paolo Soda, Mario Merone, Antonella Afeltra, Amelia Rigon

doi: 10.1136/annrheumdis-2018-214615
Correspondence response
Response to: ‘ANA testing in “real life”’ by Infantino et al
Free

David S Pisetsky, Diane M Spencer, Peter E Lipsky, Brad H Rovin

doi: 10.1136/annrheumdis-2018-214650

November 14, 2018

Correspondence response
Response to: ‘Metering the METEOR in methotrexate failure: is propensity score a falling star?’ by Ahmed et al
Free

Sytske Anne Bergstra, Cornelia F Allaart, Robert B M Landewé

doi: 10.1136/annrheumdis-2018-214652
Correspondence
Inflammation in SLE-PAH: good news or not?
Free

Junyan Qian, Mengtao Li, Jiuliang Zhao, Qian Wang, Zhuang Tian, Xiaofeng Zeng

doi: 10.1136/annrheumdis-2018-214605
Correspondence response
Response to: ‘Inflammation in SLE-PAH: good news or not?’ by Junyan Qian et al
Free

Fangfang Sun, Yunxia Lei, Xiao Zhang, Shuang Ye

doi: 10.1136/annrheumdis-2018-214647

November 12, 2018

Correspondence response
Response to: ‘Digital health: a new dimension in rheumatology patient care’ by Kataria and Ravindran
Free

Gerd R Burmester

doi: 10.1136/annrheumdis-2018-214154

November 10, 2018

Correspondence response
Response to e-letter: ‘Tocilizumab in patients with adult-onset Still’s disease refractory to glucocorticoid treatment’ by Lee
Free

Yuko Kaneko, Hideto Kameda, Kei Ikeda, Tomonori Ishii, Kosaku Murakami, Hyota Takamatsu, Yoshiya Tanaka, Takayuki Abe, Tsutomu Takeuchi

doi: 10.1136/annrheumdis-2018-214653
Correspondence
Biomarkers: to be or not to be
Free

Sule Yavuz, Lars Rönnblom

doi: 10.1136/annrheumdis-2018-214608
Correspondence response
Response to: ‘Will SPAR be useful in the usual patients with scleroderma?’ by Chattopadhyay et al
Free

Wanlong Wu, Suzana Jordan, Oliver Distler

doi: 10.1136/annrheumdis-2018-214270

October 26, 2018

Correspondence response
Response to: ‘“MAINRITSAN2-the future”, with some doubts!’ by Chattopadhyay et al
Free

Pierre Charles, Loic Guillevin

doi: 10.1136/annrheumdis-2018-214516

October 23, 2018

Correspondence
Long-term follow-up after switching from originator infliximab to its biosimilar CT-P13: the weight of nocebo effect
Free

Vincent Germain, Marc Scherlinger, Thomas Barnetche, Thierry Schaeverbeke, On behalf of the Fédération Hospitalouniversitaire ACRONIM

doi: 10.1136/annrheumdis-2018-214374
Correspondence
Effectiveness and safety of tocilizumab for the treatment of refractory systemic sclerosis associated interstitial lung disease: a case series
Free

Javier Narváez, Judit LLuch, Juan José Alegre Sancho, Maria Molina-Molina, Joan Miquel Nolla, Ivan Castellví

doi: 10.1136/annrheumdis-2018-214449
Correspondence
Prolonged treatment with Tadekinig alfa in adult-onset Still’s disease
Free

Uta Kiltz, David Kiefer, Jürgen Braun, Eduardo Jorge Schiffrin, Charlotte Girard-Guyonvarc'h, Cem Gabay

doi: 10.1136/annrheumdis-2018-214496
Correspondence response
Response to: ‘Clinical evidence guidelines in systemic lupus erythematosus: revaluation’ by Scheinberg
Free

Bernardo A Pons-Estel, Eloisa Bonfa, Enrique R Soriano, Mario Humberto Cardiel, Ariel Izcovich, Gloria Vázquez, Graciela S Alarcón

doi: 10.1136/annrheumdis-2018-214385
Correspondence response
Response to: ‘Effectiveness and safety of tocilizumab for the treatment of refractory systemic sclerosis associated interstitial lung disease: a case series’ by Narváez
Free

Dinesh Khanna, Angelika Jahreis, Celia J F Lin

doi: 10.1136/annrheumdis-2018-214477

October 18, 2018

Correspondence
Chronic hydroxychloroquine/chloroquine exposure for connective tissue diseases and risk of Alzheimer’s disease
Free

Young Ho Lee

doi: 10.1136/annrheumdis-2018-214494
Correspondence response
Response to: ‘Chronic hydroxychloroquine/chloroquine exposure for connective tissue diseases and risk of Alzheimer’s disease’ by Lee
Free

Laurence Fardet, Irene Petersen, Irwin Nazareth

doi: 10.1136/annrheumdis-2018-214515

October 12, 2018

Correspondence
‘MAINRITSAN2-the future’, with some doubts!
Free

Arghya Chattopadhyay, Nupoor Acharya, Debashish Mishra, Vikas Sharma, GSRSNK Naidu, Aman Sharma

doi: 10.1136/annrheumdis-2018-214486

October 09, 2018

Correspondence response
Response to: ‘Aortic ulceration in a tocilizumab-treated patient with Takayasu arteritis’ by Liebling et al
Free

Yoshikazu Nakaoka

doi: 10.1136/annrheumdis-2018-214239
Correspondence
Knee osteoarthritis and bisphosphonates: Could BCP crystals be the missing link?
Free

Claire-Louise M Murphy, Geraldine McCarthy

doi: 10.1136/annrheumdis-2018-214421

October 08, 2018

Editorial
Why did IL-23p19 inhibition fail in AS: a tale of tissues, trials or translation?

Stefan Siebert, Neal L Millar, Iain B McInnes

doi: 10.1136/annrheumdis-2018-213654

September 29, 2018

Correspondence response
Monocyte and macrophage phenotypes: a look beyond systemic sclerosis
Free

Maurizio Cutolo, Amelia Chiara Trombetta, Stefano Soldano

doi: 10.1136/annrheumdis-2018-214371
Correspondence
M1/M2 polarisation state of M-CSF blood-derived macrophages in systemic sclerosis
Free

Alain Lescoat, Alice Ballerie, Stephane Jouneau, Olivier Fardel, Laurent Vernhet, Patrick Jego, Valérie Lecureur

doi: 10.1136/annrheumdis-2018-214333
Correspondence
Clinical evidence guidelines in systemic lupus erythematosus: revaluation
Free

Morton Scheinberg

doi: 10.1136/annrheumdis-2018-214357

September 21, 2018

Correspondence
Coffee consumption and gout: a Mendelian randomisation study
Free

Young Ho Lee

doi: 10.1136/annrheumdis-2018-214356
Correspondence
Immune checkpoint inhibitor rechallenge in patients with immune-related myositis
Free

Julie Delyon, Florence Brunet-Possenti, Sarah Leonard-Louis, Dimitri Arangalage, Mathilde Baudet, Barouyr Baroudjian, Celeste Lebbe, Baptiste Hervier

doi: 10.1136/annrheumdis-2018-214336

September 07, 2018

Correspondence
Will SPAR be useful in the usual patients with scleroderma?
Free

Arghya Chattopadhyay, Varun Dhir, Shefali Sharma, Aman Sharma, Sanjay Jain

doi: 10.1136/annrheumdis-2018-214256

September 05, 2018

Correspondence
Revised 2017 international consensus on ANCA testing in small vessel vasculitis: support from an external quality assessment
Free

Sylvia Broeders, Sylvie Goletti, Jean-Paul Tomasi, Carolien Bonroy, René-Louis Humbel, Laurence Lutteri, Sofie Schouwers, Lieve Van Hoovels, Martine Vercammen, Xavier Bossuyt

doi: 10.1136/annrheumdis-2018-214078
Correspondence response
Response to: ‘The revised 2017 international consensus on ANCA testing in small vessel vasculitis: support from an external quality assessment’ by Broeders et al
Free

Jan Damoiseaux

doi: 10.1136/annrheumdis-2018-214243

August 27, 2018

Correspondence
Aortic ulceration in a tocilizumab-treated patient with Takayasu arteritis
Free

Emily J Liebling, Rosemary Peterson, Teresa Victoria, Jon M Burnham

doi: 10.1136/annrheumdis-2018-214191

August 20, 2018

Correspondence response
Response to: ’Dual target strategy: a proposal to mitigate the risk of overtreatment and enhance patient satisfaction in rheumatoid arthritis' by Ferreira et al

Robert B M Landewé

doi: 10.1136/annrheumdis-2018-214221
Correspondence
Dual target strategy: a proposal to mitigate the risk of overtreatment and enhance patient satisfaction in rheumatoid arthritis

Ricardo J O Ferreira, Mwidimi Ndosi, Maarten de Wit, Eduardo José Ferreira Santos, Cátia Duarte, Johannes W G Jacobs, Pedro M Machado, Désirée van der Heijde, Laure Gossec, Jose A P da Silva

doi: 10.1136/annrheumdis-2018-214199

August 17, 2018

Correspondence response
Response to ’Response to viewpoint ’Defining refractory rheumatoid arthritis' by Buch' by Roodenrijs et al

Maya H Buch

doi: 10.1136/annrheumdis-2018-214153

August 14, 2018

Correspondence
Digital health in rheumatology

Vinod Ravindran, Suchitra Kataria

doi: 10.1136/annrheumdis-2018-214146

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online First

December 05, 2018

December 04, 2018

December 01, 2018

November 28, 2018

November 24, 2018

November 20, 2018

November 17, 2018

November 14, 2018

November 12, 2018

November 10, 2018

November 08, 2018

November 02, 2018

October 29, 2018

October 26, 2018

October 23, 2018

October 18, 2018

October 12, 2018

October 09, 2018

October 08, 2018

September 29, 2018

September 21, 2018

September 07, 2018

September 05, 2018

August 27, 2018

August 20, 2018

August 17, 2018

August 14, 2018

Pages